Instanyl-5002
Completed
Assessment of Updated Educational Materials for Instanyl®
Clinicaltrials.gov
#NCT04938440EUPAS
#EUPAS41308About this clinical trial
The purpose of the Instanyl study is to learn how much doctors know and understand about Instanyl® before and after they receive updated educational information, including the risks of its unapproved use. In this study, the doctors will complete two surveys: one three months before they receive the updated educational information, and one about six months after they receive this information. They will answer questions about their prescribing behavior plus their knowledge of Instanyl® including any risks.
US
Observational clinical trial.
At a glance
What medical conditions were being studied?
Pain
Cancer Pain
How many participants were enrolled?
536
Were placebos part of the clinical trial?
No
When was the clinical trial conducted?
Feb 2022 - Feb 2023
How long was participation in the clinical trial?
Prescribers will complete 2 surveys during a 9 to 10 month period.
Key requirements
Sex
All
Age
18+ years
Healthy volunteers?
No
Entry criteria
Must have prescribed Instanyl® in the last 12 months OR intend to prescribe Instanyl®.
Additional entry criteria apply.